Vimta Labs Limited (NSE:VIMTALABS)
India · Delayed Price · Currency is INR 785.15
+8.20 (1.06%)
Sep 17, 2025, 3:30 PM IST
Vimta Labs Market Cap
Vimta Labs has a market cap or net worth of 34.58 billion as of September 17, 2025. Its market cap has increased by 142.95% in one year.
Market Cap
34.58B
Enterprise Value
34.34B
Revenue
3.68B
Ranking
n/a
PE Ratio
47.13
Stock Price
785.15
Market Cap Chart
Since January 10, 2002, Vimta Labs's market cap has increased from 19.85M to 34.58B, an increase of 174,114.17%. That is a compound annual growth rate of 37.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 34.58B | 56.40% |
| Dec 31, 2024 | 22.11B | 147.00% |
| Dec 29, 2023 | 8.95B | -7.56% |
| Dec 30, 2022 | 9.68B | 7.16% |
| Dec 31, 2021 | 9.04B | 134.75% |
| Dec 31, 2020 | 3.85B | 88.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,878.76B |
| Divi's Laboratories | 1,599.85B |
| Cipla | 1,271.89B |
| Apollo Hospitals Enterprise | 1,132.23B |
| Mankind Pharma | 1,064.75B |
| Zydus Lifesciences | 1,051.26B |
| Fortis Healthcare | 732.31B |
| Alkem Laboratories | 651.39B |